Edition:
India

Cadila Healthcare Says USFDA Inspection At Moraiya Formulations Manufacturing Facility Ended With 14 Observations


Friday, 3 May 2019 

May 3 (Reuters) - Cadila Healthcare Ltd ::USFDA INSPECTED COMPANY'S FORMULATIONS MANUFACTURING FACILITY AT MORAIYA, AHMEDABAD FROM 22ND APRIL 2019 TO 3RD MAY 2019.SAYS INSPECTION CONCLUDED WITH 14 OBSERVATIONS.THERE WERE NO REPEAT OBSERVATIONS OR DATA INTEGRITY RELATED OBSERVATIONS. 

Company Quote

261.0
-3.0 -1.14%
13 Dec 2019